IKVAV regulates ERK1/2 and Akt signalling pathways in BMMSC population growth and proliferation

Cell Proliferation

Volumn 47, Issue 2, 2014, Pages 133-145

  Li, B ^a   Qiu, T ^a   Zhang, P ^a   Wang, X ^a   Yin, Y ^a   Li, S ^a  

^a WUHAN UNIVERSITY OF TECHNOLOGY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; CHOLECYSTOKININ OCTAPEPTIDE; CYCLINE; ISOLEUCYLLYSYL VALYL ALANYL VALINE; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; PEPTIDE; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; UNCLASSIFIED DRUG; WORTMANNIN;

ARTICLE; BONE MARROW MESENCHYMAL STEM CELL; CELL CYCLE G0 PHASE; CELL CYCLE G1 PHASE; CELL CYCLE S PHASE; CELL GROWTH; CELL POPULATION; CELL PROLIFERATION; CELL VIABILITY; CONTROLLED STUDY; FLOW CYTOMETRY; HEMATOPOIETIC STEM CELL; HUMAN; HUMAN CELL; MESENCHYMAL STEM CELL; MESSENGER RNA SYNTHESIS; PROTEIN PHOSPHORYLATION; REAL TIME POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; UPREGULATION; WESTERN BLOTTING;

ANDROSTADIENES; ANIMALS; CELL CYCLE; CELL PROLIFERATION; CELL SURVIVAL; FLAVONOIDS; HUMANS; LAMININ; MAP KINASE SIGNALING SYSTEM; MESENCHYMAL STROMAL CELLS; PEPTIDE FRAGMENTS; PHOSPHATIDYLINOSITOL 3-KINASES; PROLIFERATING CELL NUCLEAR ANTIGEN; PROTO-ONCOGENE PROTEINS C-AKT; SIGNAL TRANSDUCTION; TISSUE ENGINEERING; TISSUE SCAFFOLDS;

EID: 84896836303     PISSN: 09607722     EISSN: 13652184     Source Type: Journal    
DOI: 10.1111/cpr.12094     Document Type: Article

References (84)

1. Caplan AI (1991) Mesenchymal stem cells. J. Orthop. Res. 9, 641-650.
2. Barrilleaux B, Phinney DG, Prockop DJ, O'connor KC (2006) Review: ex vivo engineering of living tissues with adult stem cells. Tissue Eng. 12, 3007-3019.
3. Timper K, Seboek D, Eberhardt M, Linscheid P, Christ-Crain M, Keller U et al. (2006) Human adipose tissue-derived mesenchymal stem cells differentiate into insulin, somatostatin, and glucagon expressing cells. Biochem. Biophys. Res. Commun. 341, 1135-1140.
4. Shake JG, Gruber PJ, Baumgartner WA, Senechal G, Meyers J, Redmond JM et al. (2002) Mesenchymal stem cell implantation in a swine myocardial infarct model: engraftment and functional effects. Ann. Thorac. Surg. 73, 1919-1926.
5. Toma C, Pittenger MF, Cahill KS, Byrne BJ, Kessler PD (2002) Human mesenchymal stem cells differentiate to a cardiomyocyte phenotype in the adult murine heart. Circulation 105, 93-98.
6. El-Ansary M, Abdel-Aziz I, Mogawer S, Abdel-Hamid S, Hammam O, Teaema S et al. (2012) Phase II trial: undifferentiated versus differentiated autologous mesenchymal stem cells transplantation in Egyptian patients with HCV induced liver cirrhosis. Stem Cell Rev. Rep. 8, 972-981.
7. Zhang Z, Lin H, Shi M, Xu R, Fu J, Lv J et al. (2012) Human umbilical cord mesenchymal stem cells improve liver function and ascites in decompensated liver cirrhosis patients. J. Gastroenterol. Hepatol. 27(Suppl 2), 112-120.
8. Peng L, Xie DY, Lin BL, Liu J, Zhu HP, Xie C et al. (2011) Autologous bone marrow mesenchymal stem cell transplantation in liver failure patients caused by hepatitis B: short-term and long-term outcomes. Hepatology 54, 820-828.
9. Yen TH, Alison MR, Cook HT, Jeffery R, Otto WR, Wright NA et al. (2007) The cellular origin and proliferative status of regenerating renal parenchyma after mercuric chloride damage and erythropoietin treatment. Cell Prolif. 40, 143-156.
10. Wise AF, Ricardo SD (2012) Mesenchymal stem cells in kidney inflammation and repair. Nephrology 17, 1-10.
11. Le Blanc K, Rasmusson I, Sundberg B, Götherström C, Hassan M, Uzunel M et al. (2004) Treatment of severe acute grat-versus-host disease with third party haploidentical mesenchymal stem cells. Lancet 363, 1439-1441.
12. Uccelli A, Moretta L, Pistoia V (2008) Mesenchymal stem cells in health and disease. Nat. Rev. Immunol. 8, 726-736.
13. Griffin M, Iqbal SA, Bayat A (2011) Exploring the application of mesenchymal stem cells in bone repair and regeneration. J. Bone Joint Surg. Br. 93, 427-434.
14. Bruder SP, Kurth AA, Shea M, Hayes WC, Jaiswal N, Kadiyala S (1998) Bone regeneration by implantation of purified, culture-expanded human mesenchymal stem cells. J. Orthop. Res. 16, 155-162.
15. Patel DM, Shah J, Srivastava AS (2013). Therapeutic potential of mesenchymal stem cells in regenerative medicine. Stem Cells Int. 2013, 1-15.
16. Krebsbach PH, Kuznetsov SA, Bianco P, Robey PG (1999) Bone marrow stromal cells: characterization and clinical application. Crit. Rev. Oral Biol. Med. 10, 165-181.
17. Pittenger MF (2010) Umbilical Cord Blood: A Future for Regenerative Medicine, pp 89-97. Singapore: World Scientific Publishing Co. Pte. Ltd.
18. Porada CD, Zanjani ED, Almeida-Porada G (2006) Adult mesenchymal stem cells: a pluripotent population with multiple applications. Curr. Stem Cell Res. Ther. 1, 365-369.
19. Silva GA, Czeisler C, Niece KL, Beniash E, Harrington DA, Kessler JA et al. (2004) Selective differentiation of neural progenitor cells by high-epitope density nanofibers. Science 303, 1352-1355.
20. Hodgkinson CP, Gomez JA, Mirotsou M, Dzau VJ (2010) Genetic engineering of mesenchymal stem cells and its application in human disease therapy. Hum. Gene Ther. 21, 1513-1526.
21. Elnakish MT, Hassan F, Dakhlallah D, Marsh CB, Alhaider IA, Khan M (2012) Mesenchymal stem cells for cardiac regeneration: translation to bedside reality. Stem Cells Int. 2012, 1-14.
22. Allers C, Sierralta WD, Neubauer S, Rivera F, Minguell JJ, Conget PA (2004) Dynamic of distribution of human bone marrow-derived mesenchymal stem cells after transplantation into adult unconditioned mice. Transplantation 78, 503-508.
23. Humes HD (2005) Stem cells: the next therapeutic frontier. Trans. Am. Clin. Climatol. Assoc. 116, 167.
24. Niland S, Cremer A, Fluck J, Eble JA, Krieg T, Sollberg S (2001) Contraction-dependent apoptosis of normal dermal fibroblasts. J. Invest. Dermatol. 116, 686-692.
25. Aizawa Y, Owen SC, Shoichet MS (2012) Polymers used to influence cell fate in 3D geometry: new trends. Prog. Polym. Sci. 37, 645-658.
26. Hosseinkhani H, Hong PD, Yu DS (2013) Self-assembled proteins and peptides for regenerative medicine. Chem. Rev. 113, 4837-4861.
27. Tashiro KI, Sephel GC, Weeks B, Sasaki M, Martin GR, Kleinman HK et al. (1989) A synthetic peptide containing the IKVAV sequence from the A chain of laminin mediates cell attachment, migration, and neurite outgrowth. J. Biol. Chem. 264, 16174-16182.
28. Graf J, Iwamoto Y, Sasaki M, Martin GR, Kleinman HK, Robey FA et al. (1987) Identification of an amino acid sequence in laminin mediating cell attachment, chemotaxis, and receptor binding. Cell 48, 989-996.
29. Adams DN, Kao EYC, Hypolite CL, Distefano MD, Hu WS, Letourneau PC (2005) Growth cones turn and migrate up an immobilized gradient of the laminin IKVAV peptide. J. Neurobiol. 62, 134-147.
30. Takahashi Y, Tabata Y (2003) Homogeneous seeding of mesenchymal stem cells into nonwoven fabric for tissue engineering. Tissue Eng. 9, 931-938.
31. Ma T, Li Y, Yang ST, Kniss DA (2000) Effects of pore size in 3-D fibrous matrix on human trophoblast tissue development. Biotechnol. Bioeng. 70, 606-618.
32. Both SK, Muijsenberg AJVD, Blitterswijk CAV, Boer JD, Bruijn JDD (2007) A rapid and efficient method for expansion of human mesenchymal stem cells. Tissue Eng. 13, 3-9.
33. Hosseinkhani H, Hosseinkhani M, Tian F, Kobayashi H, Tabata Y (2006) Osteogenic differentiation of mesenchymal stem cells in self-assembled peptide-amphiphile nanofibers. Biomaterials 27, 4079-4086.
34. Hosseinkhani H, Hosseinkhani M, Tian F, Kobayashi H, Tabata Y (2006) Ectopic bone formation in collagen sponge self-assembled peptide-amphiphile nanofibers hybrid scaffold in a perfusion culture bioreactor. Biomaterials 27, 5089-5098.
35. Rice JJ, Martino MM, De Laporte L, Tortelli F, Briquez PS, Hubbell JA (2013) Engineering the regenerative microenvironment with biomaterials. Adv. Healthc. Mater. 2, 57-71.
36. Hosseinkhani H, Hosseinkhani M, Khademhosseini A, Kobayashi H (2007) Bone regeneration through controlled release of bone morphogenetic protein-2 from 3-D tissue engineered nano-scaffold. J. Control. Release 117, 380-386.
37. Hosseinkhani H, Hosseinkhani M, Khademhosseini A, Kobayashi H, Tabata Y (2006) Enhanced angiogenesis through controlled release of basic fibroblast growth factor from peptide amphiphile for tissue regeneration. Biomaterials 27, 5836-5844.
38. Santiago LY, Nowak RW, Peter Rubin J, Marra KG (2006) Peptide-surface modification of poly (caprolactone) with laminin-derived sequences for adipose-derived stem cell applications. Biomaterials 27, 2962-2969.
39. Yu LM, Kazazian K, Shoichet MS (2007) Peptide surface modification of methacrylamide chitosan for neural tissue engineering applications. J. Biomed. Mater. Res. A 82, 243-255.
40. Kasai S, Ohga Y, Mochizuki M, Nishi N, Kadoya Y, Nomizu M (2004) Multifunctional peptide fibrils for biomedical materials. Pept. Sci. 76, 27-33.
41. Hosseinkhani H, Hiraoka Y, Li CH, Chen YR, Yu DS, Hong PD et al. (2013) Engineering 3D collagen-IKVAV matrix to mimic neural microenvironment. ACS Chem. Neurosci. 4, 1229-1235.
42. Matsuda A, Kobayashi H, Itoh S, Kataoka K, Tanaka J (2005) Immobilization of laminin peptide in molecularly aligned chitosan by covalent bonding. Biomaterials 26, 2273-2279.
43. Tysseling-Mattiace VM, Sahni V, Niece KL, Birch D, Czeisler C, Fehlings MG et al. (2008) Self-assembling nanofibers inhibit glial scar formation and promote axon elongation after spinal cord injury. J. Neurosci. 28, 3814-3823.
44. Jongpaiboonkit L, King WJ, Murphy WL (2008) Screening for 3D environments that support human mesenchymal stem cell viability using hydrogel arrays. Tissue Eng. Part A 15, 343-353.
45. Singh A, Elisseeff J (2010) Biomaterials for stem cell differentiation. J. Mater. Chem. 20, 8832-8847.
46. Cooke MJ, Vulic K, Shoichet MS (2010) Design of biomaterials to enhance stem cell survival when transplanted into the damaged central nervous system. Soft Matter 6, 4988-4998.
47. Kubinová Š, Horák D, Kozubenko N, Vaněček V, Proks V, Price J et al. (2010) The use of superporous Ac-CGGASIKVAVS-OH-modified PHEMA scaffolds to promote cell adhesion and the differentiation of human fetal neural precursors. Biomaterials 31, 5966-5975.
48. Schaeffer HJ, Weber MJ (1999) Mitogen-activated protein kinases: specific messages from ubiquitous messengers. Mol. Cell. Biol. 19, 2435-2444.
49. Schmitz KJ, Wohlschlaeger J, Lang H, Sotiropoulos GC, Malago M, Steveling K et al. (2008) Activation of the ERK and AKT signalling pathway predicts poor prognosis in hepatocellular carcinoma and ERK activation in cancer tissue is associated with hepatitis C virus infection. J. Hepatol. 48, 83-90.
50. Franke TF (1999) A difficult Akt to follow. Neural Notes 5, 3-7.
51. Franke TF, Kaplan DR, Cantley LC (1997) PI3K: downstream AKT ion blocks apoptosis. Cell 88, 435.
52. Jones NC, Fedorov YV, Rosenthal RS, Olwin BB (2001) ERK1/2 is required for myoblast proliferation but is dispensable for muscle gene expression and cell fusion. J. Cell. Physiol. 186, 104-115.
53. Coolican SA, Samuel DS, Ewton DZ, McWade FJ, Florini JR (1997) The mitogenic and myogenic actions of insulin-like growth factors utilize distinct signaling pathways. J. Biol. Chem. 272, 6653-6662.
54. Choi SC, Kim SJ, Choi JH, Park CY, Shim WJ, Lim DS (2008) Fibroblast growth factor-2 and-4 promote the proliferation of bone marrow mesenchymal stem cells by the activation of the PI3K-Akt and ERK1/2 signaling pathways. Stem Cells Dev. 17, 725-736.
55. Ryu CH, Park SA, Kim SM, Lim JY, Jeong CH, Jun J et al. (2010) Migration of human umbilical cord blood mesenchymal stem cells mediated by stromal cell-derived factor-1/CXCR4 axis via Akt, ERK, and p38 signal transduction pathways. Biochem. Biophys. Res. Commun. 398, 105-110.
56. Li B (2012). Isolation of BMMSCs and its Effect on Spinal Cord Repair Materials [D]. Wuhan: Wuhan University of Technology. (in Chinese).
57. Yuan T (2012). Preparation and Characterization of YIGSR and IKVAV Peptides Grafted Hydrogel [D]. Wuhan: Wuhan University of Technology. (in Chinese).
58. Alessi DR, Cuenda A, Cohen P, Dudley DT, Saltiel AR (1995) PD98059 is a specific inhibitor of the activation of mitogen activated protein kinase in vitro and in vivo. J. Biol. Chem. 270, 27489-27494.
59. Wipf P, Halter RJ (2005) Chemistry and biology of wortmannin. Org. Biomol. Chem. 3, 2053-2061.
60. Ranieri JP, Bellamkonda R, Bekos EJ, Gardella JA Jr, Mathieu HJ, Ruiz L et al. (1994) Spatial control of neuronal cell attachment and differentiation on covalently patterned laminin oligopeptide substrates. Int. J. Dev. Neurosci. 12, 725-735.
61. Smith MW, Newey JM (1960) Amino acid and peptide transport across the mammalian small intestine. Protein Melab. Nutr. 64, 213-219.
62. Zhu J (2010) Bioactive modification of poly (ethylene glycol) hydrogels for tissue engineering. Biomaterials 31, 4639-4656.
63. Drury JL, Mooney DJ (2003) Hydrogels for tissue engineering: scaffold design variables and applications. Biomaterials 24, 4337-4351.
64. Shekaran A, Garcia AJ (2011) Nanoscale engineering of extracellular matrix-mimetic bioadhesive surfaces and implants for tissue engineering. Biochim. Biophys. Acta, 1810, 350-360.
65. Elbert DL, Hubbell JA (1996) Surface treatments of polymers for biocompatibility. Annu. Rev. Mater. Sci. 26, 365-294.
66. Zou Z, Zheng Q, Wu Y, Song Y, Wu B (2009) Growth of rat dorsal root ganglion neurons on a novel self-assembling scaffold containing IKVAV sequence. Mater. Sci. Eng., C 29, 2099-2103.
67. Lévesque SG, Shoichet MS (2006) Synthesis of cell-adhesive dextran hydrogels and macroporous scaffolds. Biomaterials 27, 5277-5285.
68. Cui FZ, Tian WM, Fan YW, Hou SP, Xu QY, Lee IS (2003) Cerebrum repair with PHPMA hydrogel immobilized with neurite-promoting peptides in traumatic brain injury of adult rat model. J. Bioact. Compat. Polym. 18, 413-432.
69. Tysseling-Mattiace VM, Sahni V, Niece KL, Birch D, Czeisler C, Fehlings MG et al. (2008) Self-assembling nanofibers inhibit glial scar formation and promote axon elongation after spinal cord injury. J. Neurosci. 28, 3814-3823.
70. Wu B, Zheng Q, Wu Y, Guo X, Zou Z (2010) Effect of IKVAV peptide nanofiber on proliferation, adhesion and differentiation into neurocytes of bone marrow stromal cells. J. Huazhong Univ. Sci. Technol. Med. Sci. 30, 178-182.
71. Li X, Liu L, Meng D, Wang D, Zhang J, Shi D et al. (2012) Enhanced apoptosis and senescence of bone-marrow-derived mesenchymal stem cells in patients with systemic lupus erythematosus. Stem Cells Dev. 21, 2387-2394.
72. Sasaki K, Kurose A, Ishida Y (1993) Flow cytometric analysis of the expression of PCNA during the cell cycle in HeLa cells and effects of the inhibition of DNA synthesis on it. Cytometry 14, 876-882.
73. Hall PA, Levison DA, Woods AL, Yu CW, Kellock DB, Watkins JA et al. (1990) Proliferating cell nuclear antigen (PCNA) immunolocalization in paraffin sections: an index of cell proliferation with evidence of deregulated expression in some, neoplasms. J. Pathol. 162, 285-294.
74. Steelman LS, Pohnert SC, Shelton JG, Franklin RA, Bertrand FE, McCubrey JA (2004) JAK/STAT, Raf/MEK/ERK, PI3K/Akt and BCR-ABL in cell cycle progression and leukemogenesis. Leukemia 18, 189-218.
75. Peng CY, Pan SL, Huang YW, Guh JH, Chang YL, Teng CM (2008) Baicalein attenuates intimal hyperplasia after rat carotid balloon injury through arresting cell-cycle progression and inhibiting ERK, Akt, and NF-κB activity in vascular smooth-muscle cells. Naunyn Schmiedeberg's Arch. Pharmacol. 378, 579-588.
76. Bernardi RJ, Trump DL, Yu WD, McGuire TF, Hershberger PA, Johnson CS (2001) Combination of 1α, 25-dihydroxyvitamin D3 with dexamethasone enhances cell cycle arrest and apoptosis role of nuclear receptor cross-talk and Erk/Akt signaling. Clin. Cancer Res. 7, 4164-4173.
77. Roy SK, Srivastava RK, Shankar S (2010) Inhibition of PI3K/AKT and MAPK/ERK pathways causes activation of FOXO transcription factor, leading to cell cycle arrest and apoptosis in pancreatic cancer. J. Mol. Signal. 5, 10.
78. Chang L, Karin M (2001) Mammalian MAP kinase signaling cascades. Nature 410, 37-40.
79. Dhennin-Duthille I, Masson M, Damiens E, Fillebeen C, Spik G, Mazurier J (2000) Lactoferrin upregulates the expression of CD4 antigen through the stimulation of the mitogen-activated protein kinase in the human lymphoblastic T Jurkat cell line. J. Cell. Biochem. 79, 583-593.
80. Yamamoto T, Ebisuya M, Ashida F, Okamoto K, Yonehara S, Nishida E (2006) Continuous ERK activation downregulates antiproliferative genes throughout G1 phase to allow cell-cycle progression. Curr. Biol. 16, 1171-1182.
81. Shin I, Yakes FM, Rojo F, Shin NY, Bakin AV, Baselga J et al. (2002) PKB/Akt mediates cell-cycle progression by phosphorylation of p27Kip1 at threonine 157 and modulation of its cellular localization. Nat. Med. 8, 1145-1152.
82. Brunet A, Bonni A, Zigmond MJ, Lin MZ, Juo P, Hu LS et al. (1999) Akt promotes cell survival by phosphorylating and inhibiting a Forkhead transcription factor. Cell, 96, 857-868.
83. Bravo R (1986) Synthesis of the nuclear protein cyclin (PCNA) and its relationship with DNA replication. Exp. Cell Res. 163, 287-293.
84. Celis JE, Celis A (1985) Individual nuclei in polykaryons can control cyclin distribution and DNA synthesis. EMBO J. 4, 1187.